247 related articles for article (PubMed ID: 26349768)
1. Altered macrophagic THP-1 cell phagocytosis and migration in bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Hoefert S; Sade Hoefert C; Munz A; Northoff H; Yuan A; Reichenmiller K; Reinert S; Grimm M
Clin Oral Investig; 2016 Jun; 20(5):1043-54. PubMed ID: 26349768
[TBL] [Abstract][Full Text] [Related]
2. Effect of bisphosphonates on macrophagic THP-1 cell survival in bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Hoefert S; Sade Hoefert C; Munz A; Schmitz I; Grimm M; Yuan A; Northoff H; Reinert S; Alexander D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):222-32. PubMed ID: 26725718
[TBL] [Abstract][Full Text] [Related]
3. Zoledronate but not denosumab suppresses macrophagic differentiation of THP-1 cells. An aetiologic model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Hoefert S; Hoefert CS; Albert M; Munz A; Grimm M; Northoff H; Reinert S; Alexander D
Clin Oral Investig; 2015 Jul; 19(6):1307-18. PubMed ID: 25411080
[TBL] [Abstract][Full Text] [Related]
4. Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
Otto S; Pautke C; Opelz C; Westphal I; Drosse I; Schwager J; Bauss F; Ehrenfeld M; Schieker M
J Oral Maxillofac Surg; 2010 Nov; 68(11):2837-45. PubMed ID: 20971371
[TBL] [Abstract][Full Text] [Related]
5. Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database.
Amigues C; Fresse A; Roux CH; Gauthier S; Vieillard MH; Drici MD; Breuil V;
Joint Bone Spine; 2023 Dec; 90(6):105599. PubMed ID: 37271278
[TBL] [Abstract][Full Text] [Related]
6. High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis.
Manzano-Moreno FJ; Ramos-Torrecillas J; De Luna-Bertos E; Ruiz C; García-Martínez O
J Craniomaxillofac Surg; 2015 Apr; 43(3):396-401. PubMed ID: 25614214
[TBL] [Abstract][Full Text] [Related]
7. Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases.
Hoefert S; Schmitz I; Weichert F; Gaspar M; Eufinger H
Clin Oral Investig; 2015 Mar; 19(2):497-508. PubMed ID: 24957986
[TBL] [Abstract][Full Text] [Related]
8. Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing.
Otto M; Lux C; Schlittenbauer T; Halling F; Ziebart T
Oral Maxillofac Surg; 2022 Jun; 26(2):321-332. PubMed ID: 34392434
[TBL] [Abstract][Full Text] [Related]
9. Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.
Mast G; Otto S; Mücke T; Schreyer C; Bissinger O; Kolk A; Wolff KD; Ehrenfeld M; Stürzenbaum SR; Pautke C
J Craniomaxillofac Surg; 2012 Oct; 40(7):568-71. PubMed ID: 22118926
[TBL] [Abstract][Full Text] [Related]
10. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
O'Ryan FS; Lo JC
J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
[TBL] [Abstract][Full Text] [Related]
13. Alteration of macrophage viability, differentiation, and function by bisphosphonates.
Patntirapong S; Poolgesorn M
Oral Dis; 2018 Oct; 24(7):1294-1302. PubMed ID: 29869362
[TBL] [Abstract][Full Text] [Related]
14. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes.
Hagelauer N; Pabst AM; Ziebart T; Ulbrich H; Walter C
Clin Oral Investig; 2015 Jan; 19(1):139-48. PubMed ID: 24668343
[TBL] [Abstract][Full Text] [Related]
16. Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.
López-Cedrún JL; Sanromán JF; García A; Peñarrocha M; Feijoo JF; Limeres J; Diz P
Br J Oral Maxillofac Surg; 2013 Dec; 51(8):874-9. PubMed ID: 23866309
[TBL] [Abstract][Full Text] [Related]
17. Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis.
Schaudinn C; Gorur A; Webster P; Jones AC; Neely M; Jelliffe RW; Le AD; Sedghizadeh PP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):480-6. PubMed ID: 22986243
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.
Pelaz A; Junquera L; Gallego L; García-Consuegra L; García-Martínez L; Cutilli T; Olay S
Acta Otorrinolaringol Esp; 2015; 66(3):139-47. PubMed ID: 25308796
[TBL] [Abstract][Full Text] [Related]
19. Depletion of macrophages deteriorates bisphosphonate-related osteonecrosis of the jaw-like lesions in mice.
Kozutsumi R; Kuroshima S; Al-Omari FA; Hayano H; Nakajima K; Kakehashi H; Sawase T
Bone; 2023 Dec; 177():116899. PubMed ID: 37708951
[TBL] [Abstract][Full Text] [Related]
20. [Effects of four bisphosphonates on macrophage phagocytosis: quantitative measurement by flow cytometry using high-fluorescence particles and human monocytic cell line THP-1].
Imoto S; Saigo K; Bohgaki M; Matsumoto E; Goto M
Rinsho Byori; 2014 Jan; 62(1):23-30. PubMed ID: 24724423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
